A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice.
about
Characterization of the murine myeloid precursor cell line MuMac-E8Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyMouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in MiceIntratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity.Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancerEx vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancerA core of kinase-regulated interactomes defines the neoplastic MDSC lineage.Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.Dynamics of the spleen and its significance in a murine H22 orthotopic hepatoma model.Drafting the proteome landscape of myeloid-derived suppressor cells.In vitro exploration of a myeloid-derived suppressor cell line as vehicle for cancer gene therapy.Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer.Myeloid-derived suppressor cells as effectors of immune suppression in cancer.PD1 signal transduction pathways in T cells.Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives.Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.The intracellular signalosome of PD-L1 in cancer cellsTurn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
P2860
Q27323184-4ECC2DD6-F97C-47E6-A528-BDF16E4B6B29Q28080262-C9F30D1B-5488-4B09-8EB4-AB638BB74A48Q33821025-18094123-03A3-4015-8898-17707C6AB2E6Q34654430-3D1476B8-56DF-420E-8B88-48E06AA65643Q34956969-6113866C-A1ED-430B-9C85-51D8F683232CQ35828574-B6B32AB2-1623-4E93-8248-3438A9867848Q36413721-41C15026-6922-475E-B34A-C262B3EDDE99Q36545406-F6B82D22-EA4A-450E-88F9-D203D90A1B4FQ37107253-8DE1194A-E863-4142-AB9C-D5E2A1E6D5E6Q38592376-670CFF7D-18A1-4106-A9FF-C7D6E6AC2780Q38730553-1DB93125-9065-4786-BCA0-606A44827B57Q38849614-78490697-21C3-4ADD-A076-FC6B3ECE8CD8Q38864758-DC48F5A6-92B7-4287-9786-725AF4B57C10Q40062424-84E83BE1-3D46-4CF0-B22A-364A3C0CC4F3Q47651773-658BC0DB-27B5-47B5-A791-3B46F31CBF4AQ50443511-4AEB42A9-6BFD-4E8A-8B31-5CA2E29B79D8Q57067759-A7FACBE0-DB62-43BE-94EC-7B57CF95469CQ58780996-9C452D3E-9E54-40F6-AE18-7D4A831039F8
P2860
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A highly efficient tumor-infil ...... r tumor establishment in mice.
@ast
A highly efficient tumor-infil ...... r tumor establishment in mice.
@en
A highly efficient tumor-infil ...... r tumor establishment in mice.
@nl
type
label
A highly efficient tumor-infil ...... r tumor establishment in mice.
@ast
A highly efficient tumor-infil ...... r tumor establishment in mice.
@en
A highly efficient tumor-infil ...... r tumor establishment in mice.
@nl
prefLabel
A highly efficient tumor-infil ...... r tumor establishment in mice.
@ast
A highly efficient tumor-infil ...... r tumor establishment in mice.
@en
A highly efficient tumor-infil ...... r tumor establishment in mice.
@nl
P2093
P2860
P50
P356
P1433
P1476
A highly efficient tumor-infil ...... r tumor establishment in mice.
@en
P2093
David Escors
Enrique Santamaria
Frederick Arce
Idoia Blanco-Luquin
Kevin Van der Jeught
Maria Gato
Noemi Perez-Janices
Therese Liechtenstein
P2860
P304
P356
10.18632/ONCOTARGET.2279
P407
P577
2014-09-01T00:00:00Z